Sign in →

Test Code LAB3031 Factor V Leiden

Important Note

Note that this test can be ordered individually or as part of a thrombosis risk panel (LAB3498) that includes the prothrombin 20210G>A mutation in the F2 gene.

Clinical System Name

Factor V Leiden Mutation - DNA

Synonyms

Factor 5 Leiden

Factor V Leiden

Factor V PCR

DNA-Factor V

Factor 5 DNA Screen

APC CoFactor-DNA

Description

The factor V Leiden variant (commonly known as R506Q, p.Arg506Gln, 1691G>A) in the factor V gene (F5) is present in approximately 3% of the general population, and in about 20-50% of patients with a history of unexplained recurrent venous thrombosis. The presence of a glutamine instead of an arginine residue removes a site in factor V that is normally cleaved by activated protein C, and is associated with resistance to activated protein C. Presence of this polymorphism substantially increases the lifetime risk of venous thrombosis. This test detects the underlying defect present in almost all cases of resistance to activated protein C.

 

 

Sample Requirements

Specimen: Whole Blood

Container(s): Lavender/EDTA or Yellow/ACD A or B
Preferred Vol: 3.0 mL (Adult), 2mL (child)

Minimum Vol: 1.0 mL

 

Specimen: DNA

Container(s): Sterile plastic tube

Preferred Vol: 20-30 ul of 100ng/ul concentration

 

Note: Only one sample is needed to perform both Factor V Leiden and Prothrombin Variant.

 

Alternative Specimen (e.g. salvia or buccal): Alternate Specimen Collection Kits for Genetic Testing

Processing Instructions

Reject due to: Dark Green/Sodium Heparin, Lt. Green/Lithium Heparin Microtainer

Spin: N

Aliquot: N

Temp: 2 - 4 C

Storage location: CPA 3 refrigerator, Send Outs rack.

Stability

Specimen Type Temperature Time
Whole Blood Room Temp 7 d
  Refrigerated 7 d
  Frozen Unacceptable
Extracted DNA Room Temp 3-4 d
  Refrigerated 1 y
  Frozen Indefinitely

 

Availability

STAT Performed TAT
N Weekly 2 w

 

Performing Laboratory

University of Washington

Department of Laboratory Medicine

UW Genetics Lab
1959 NE Pacific St, NW220
Seattle, WA 98195

Phone Number: (206) 520-4600

Department

Department: Send Outs/Genetic
Phone Number: (206) 987-2563

Reference Range

Normal result: no mutations detected.

Methodology

Method: Next-generation sequencing

Analysis of the F5 gene for the Leiden (p.R506Q) mutation.

The presence of either normal (Arg506/1691G) or mutant (Gln506/1691A; also known as Factor V Leiden) alleles of the F5 gene are detected by melting curve analysis of an amplified gene product. The Factor V Leiden variant is officially designated as NM_000130.4:c.1601G>A; NP_000121.2:p.Arg534Gln. This test was developed and its performance characteristics determined by the Department of Laboratory Medicine at the University of Washington.

Special Instructions

UWMC

Test Requisition

Clinical Utility

Factor V Leiden Thrombophilia GeneReviews

The factor V Leiden mutation in the F5 gene is the most common cause of activated protein C (APC) resistance, and most common genetic risk factor for thrombosis. Approximately 3-8% of the population is heterozygous, and have an estimated 5-10 fold increased risk of thrombosis. Homozygotes have a 50-100 fold increased risk.

Send Out Instructions

Reference Test Name: Factor V DNA Screen
Reference Test Number: F5DNA
Instructions: Send out Monday through Friday with the UW courier.

Exclude from UM database